Ensysce Biosciences, Inc.ENSCNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank16
Year-over-Year Change
Year-over-year total asset growth rate
Percentile
P16
Within normal range
vs 3Y Ago
-10x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -42.96% |
| Q2 2025 | 20.87% |
| Q1 2025 | -17.60% |
| Q4 2024 | -40.36% |
| Q3 2024 | 235.69% |
| Q2 2024 | -44.91% |
| Q1 2024 | 87.37% |
| Q4 2023 | -15.86% |
| Q3 2023 | -49.37% |
| Q2 2023 | 62.40% |
| Q1 2023 | -33.48% |
| Q4 2022 | -29.01% |
| Q3 2022 | 4.29% |
| Q2 2022 | -35.75% |
| Q1 2022 | -24.64% |
| Q4 2021 | 68.94% |
| Q3 2021 | 5.67% |
| Q2 2021 | 674.70% |
| Q1 2021 | 237.42% |
| Q4 2020 | -97.35% |
| Q3 2020 | -0.91% |
| Q2 2020 | -78.23% |
| Q1 2020 | -68.65% |
| Q4 2019 | -5.16% |
| Q3 2019 | 0.41% |
| Q2 2019 | 0.39% |
| Q1 2019 | 0.35% |
| Q4 2018 | 0.39% |
| Q3 2018 | 1.34% |
| Q2 2018 | -0.76% |
| Q1 2018 | 1.38% |
| Q4 2017 | 49929.78% |
| Q3 2017 | 0.00% |